Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection

SUMMARY The intracellular protozoan Toxoplasma gondii is a widespread opportunistic parasite of humans and animals. Normally, T. gondii establishes itself within brain and skeletal muscle tissues, persisting for the life of the host. Initiating and sustaining strong T-cell-mediated immunity is crucial in preventing the emergence of T. gondii as a serious pathogen. The parasite induces high levels of gamma interferon (IFN-γ) during initial infection as a result of early T-cell as well as natural killer (NK) cell activation. Induction of interleukin-12 by macrophages is a major mechanism driving early IFN-γ synthesis. The latter cytokine, in addition to promoting the differentiation of Th1 effectors, is important in macrophage activation and acquisition of microbicidal functions, such as nitric oxide release. During chronic infection, parasite-specific T lymphocytes release high levels of IFN-γ, which is required to prevent cyst reactivation. T-cell-mediated cytolytic activity against infected cells, while easily demonstrable, plays a secondary role to inflammatory cytokine production. While part of the clinical manifestations of toxoplasmosis results from direct tissue destruction by the parasite, inflammatory cytokine-mediated immunopathologic changes may also contribute to disease progression.

[1]  S. Reed,et al.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.

[2]  K. Sugane,et al.  Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells. , 1989, The Journal of parasitology.

[3]  P. Allen,et al.  Costimulation of T Cell Activation by Integrin-associated Protein (CD47) Is an Adhesion-dependent, CD28-independent Signaling Pathway , 1997, The Journal of experimental medicine.

[4]  T. Gajewski,et al.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. , 1988, Journal of immunology.

[5]  K. Joiner,et al.  The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Kaufmann,et al.  Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. , 1994, Immunobiology.

[7]  R. Tarleton,et al.  Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. , 1996, Journal of immunology.

[8]  J. Dubremetz,et al.  Subcellular localization of the 54-kDa antigen of Toxoplasma gondii. , 1993, The Journal of parasitology.

[9]  G. Strickland,et al.  Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii , 1976, Nature.

[10]  F. Derouin,et al.  Protective effect of low doses of an anti‐IL‐4 monoclonal antibody in a murine model of acute toxoplasmosis , 1995, Parasite immunology.

[11]  K. Joiner,et al.  Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. , 1990, Science.

[12]  G. DosReis,et al.  Programmed T-cell death in experimental chagas disease. , 1995, Parasitology today.

[13]  J. Remington,et al.  Immunity and Intracellular Infection: Resistance to Bacteria in Mice Infected with a Protozoan , 1968, Science.

[14]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[15]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[16]  A. Sher,et al.  CD8+ T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. , 1993, Research in immunology.

[17]  A. Sher,et al.  Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. , 1996, Journal of immunology.

[18]  H. Hisaeda,et al.  Mechanisms of HSP65 expression induced by gamma delta T cells in murine Toxoplasma gondii infection. , 1996, Pathobiology : journal of immunopathology, molecular and cellular biology.

[19]  T. Mosmann,et al.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.

[20]  Y. Suzuki,et al.  Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice , 1997, Infection and immunity.

[21]  I. Khan,et al.  Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. , 1996, Journal of immunology.

[22]  B. Schoel,et al.  Phosphate is essential for stimulation of Vγ9Vδ2 T lymphocytes by mycobacterial low molecular weight ligand , 1994 .

[23]  J. Dubremetz,et al.  Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens , 1990, Infection and immunity.

[24]  I. Khan,et al.  Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice. , 1994, Journal of immunology.

[25]  R. Good,et al.  Heat shock protein 65 induced by gammadelta T cells prevents apoptosis of macrophages and contributes to host defense in mice infected with Toxoplasma gondii. , 1997, Journal of immunology.

[26]  C. Roberts,et al.  Different roles for interleukin-4 during the course of Toxoplasma gondii infection , 1996, Infection and immunity.

[27]  C. Roberts,et al.  CD8+ T cells arethemajorlymphocyte subpopulation involved inthe protective immuneresponsetoToxoplasma gondii inmice , 1991 .

[28]  D. Umetsu,et al.  Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. , 1997, Journal of immunology.

[29]  S. Roncella,et al.  An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. , 1988, Journal of immunology.

[30]  M. Lenardo,et al.  Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.

[31]  J. Orange,et al.  IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. , 1994, Journal of immunology.

[32]  M. Kronenberg,et al.  Mouse T lymphocytes that express a gamma delta T-cell antigen receptor contribute to resistance to Salmonella infection in vivo , 1994, Infection and immunity.

[33]  A. Sher,et al.  Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo , 1996, The Journal of experimental medicine.

[34]  G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[35]  E. Pfefferkorn Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Sher,et al.  Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. , 1993, Infectious agents and disease.

[37]  Y. Suzuki,et al.  Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection , 1989, Journal of clinical microbiology.

[38]  M. Caligiuri,et al.  Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. , 1995, The Journal of clinical investigation.

[39]  C. Hunter,et al.  Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii , 1997, Infection and immunity.

[40]  P. Linsley,et al.  The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. , 1997, Journal of immunology.

[41]  E. Unanue,et al.  Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse , 1991, Immunological reviews.

[42]  S. Kyes,et al.  Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells , 1990, The Journal of experimental medicine.

[43]  A. Sher,et al.  Immunologic Control of Toxoplasma gondii Infection by CD8+ Lymphocytes: A Model for Class I MHC-Restricted Recognition of Intracellular Parasites , 1993 .

[44]  J. Waring,et al.  Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.

[45]  R. Schreiber,et al.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. , 1988, Science.

[46]  J. Burke,et al.  Temporal differences in the expression of mRNA for IL‐10 and IFN‐γ in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii , 1994, Parasite immunology.

[47]  Y. Suzuki,et al.  Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii , 1997, Infection and immunity.

[48]  O. Wiestler,et al.  Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. , 1997, The American journal of pathology.

[49]  R. McLeod,et al.  Phenotypes and functions of lymphocytes in congenital toxoplasmosis. , 1990, The Journal of laboratory and clinical medicine.

[50]  A. Sher,et al.  Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. , 1993, Journal of immunology.

[51]  M. de Carli,et al.  Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. , 1994, Science.

[52]  C. Roberts,et al.  Detection of cytokine mRNA in the brains of mice with toxoplasmic encephalitis , 1992, Parasite immunology.

[53]  A. Fauci,et al.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.

[54]  M. Sporn,et al.  Deactivation of macrophages by transforming growth factor-beta. , 1988, Nature.

[55]  S. Kaufmann,et al.  Phosphate is essential for stimulation of V gamma 9V delta 2 T lymphocytes by mycobacterial low molecular weight ligand. , 1994, European journal of immunology.

[56]  G. Trinchieri,et al.  Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga, , 1993 .

[57]  R. McLeod,et al.  Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. , 1990, Journal of immunology.

[58]  G. Grau,et al.  Role of TNF and IL-1 in infections with Toxoplasma gondii. , 1990, Immunology.

[59]  J. Boothroyd,et al.  Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. , 1992, Journal of immunology.

[60]  L. Johnson A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection , 1992, Infection and immunity.

[61]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[62]  Somesh D. Sharma,et al.  Natural killer cells induced by acute and chronic toxoplasma infection. , 1982, Cellular immunology.

[63]  R. Ahmed,et al.  Molecular Pathways of CTL‐mediated Cytotoxicity , 1995, Immunological reviews.

[64]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[65]  P. Overath,et al.  Course of Leishmania infection in beta 2-microglobulin-deficient mice. , 1993, Immunology letters.

[66]  C. Watts,et al.  Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.

[67]  V. Nussenzweig,et al.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.

[68]  T. Curiel,et al.  CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans , 1996, Infection and immunity.

[69]  E. Petricoin,et al.  Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[70]  G. Trinchieri,et al.  The Interleukin 12 P40 Gene Promoter Is Primed by Interferon ~/in Monocytic Cells , 1996 .

[71]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[72]  P. Vassalli,et al.  Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. K. Frenkel Pathophysiology of toxoplasmosis. , 1988, Parasitology today.

[74]  G. Trinchieri,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[75]  Giorgio,et al.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.

[76]  A. Sher,et al.  HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. , 1995, Journal of immunology.

[77]  L. Kasper,et al.  Strain-specific antigens of Toxoplasma gondii , 1987, Infection and immunity.

[78]  K. Rock,et al.  Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.

[79]  R. McLeod,et al.  Immunogenetics influence outcome of Toxoplasma gondii infection. , 1993, Research in immunology.

[80]  T. Mosmann,et al.  The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991, Immunology today.

[81]  Y. Suzuki,et al.  A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. , 1991, Immunology.

[82]  J. Remington,et al.  Toxoplasmosis in the compromised host. , 1976, Annals of internal medicine.

[83]  P. Overath,et al.  Course of Leishmania infection in β2-microglobulin-deficient mice , 1993 .

[84]  F. Araújo Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice. , 1992, Journal of immunology.

[85]  A. Sher,et al.  CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. , 1991, Journal of immunology.

[86]  J. Remington,et al.  Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. , 1971, The Journal of infectious diseases.

[87]  E. Denkers,et al.  Toxoplasma gondii Triggers Granulocyte-Dependent Cytokine-Mediated Lethal Shock ind-Galactosamine-Sensitized Mice , 1998, Infection and Immunity.

[88]  G. Guyatt,et al.  Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[89]  Y. Suzuki,et al.  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. , 1988, Journal of immunology.

[90]  A. Weinberg,et al.  IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.

[91]  J. Remington,et al.  EFFECT OF NORMAL AND ACTIVATED HUMAN MACROPHAGES ON TOXOPLASMA GONDII , 1974, The Journal of experimental medicine.

[92]  A. Sher,et al.  Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice , 1993, The Journal of experimental medicine.

[93]  A. Sher,et al.  Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses , 1992, Infection and immunity.

[94]  J. Remington,et al.  Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. , 1991, Journal of immunology.

[95]  J. Berzofsky,et al.  Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum , 1988, Nature.

[96]  J. Remington,et al.  Toxoplasmosis: the time has come. , 1988, The New England journal of medicine.

[97]  A. Sher,et al.  Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. , 1998, Journal of immunology.

[98]  S. James Role of nitric oxide in parasitic infections. , 1995, Microbiological reviews.

[99]  R. Zinkernagel,et al.  The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses , 1995, European journal of immunology.

[100]  L. F. Fajardo,et al.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. , 1987, Science.

[101]  J. Blackwell,et al.  Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H‐2 congenic mice , 1993, Parasite immunology.

[102]  B. Navia,et al.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients , 1986, Annals of neurology.

[103]  J. K. Frenkel,et al.  Toxoplasmosis in nude mice. , 1977, The Journal of parasitology.

[104]  A. Sher,et al.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.

[105]  S. Tonegawa,et al.  Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[106]  T. Mosmann,et al.  The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991 .

[107]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[108]  R. S. Williams,et al.  Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer , 1990, Nature.

[109]  R. Ueda,et al.  Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[110]  J. K. Frenkel Adoptive immunity to intracellular infection. , 1967, Journal of immunology.

[111]  Y. Yoshikai,et al.  Sequential appearance of γ/δ‐ and α/β‐bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes , 1990 .

[112]  C. Hunter,et al.  Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. , 1994, The Journal of infectious diseases.

[113]  J. Remington,et al.  Antibody responses to toxoplasma antigens in mice infected with strains of different virulence , 1980, Infection and immunity.

[114]  S. Landolfo,et al.  Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation. , 1988, Journal of immunology.

[115]  B. Bloom,et al.  Natural and synthetic non-peptide antigens recognized by human γδ T cells , 1995, Nature.

[116]  H. Murray,et al.  Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages , 1989, Infection and immunity.

[117]  A. Sher,et al.  In Vivo Microbial Stimulation Induces Rapid CD40 Ligand–independent Production of Interleukin 12 by Dendritic Cells and their Redistribution to T Cell Areas , 1997, The Journal of experimental medicine.

[118]  K. Takeshita,et al.  Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[119]  R. Coffman,et al.  Regulation of immunity to parasites by T cells and T cell-derived cytokines. , 1992, Annual review of immunology.

[120]  A. Sher,et al.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. , 1991, Journal of immunology.

[121]  H. Murray,et al.  L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. , 1992, The Journal of infectious diseases.

[122]  A. Sher,et al.  Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.

[123]  A. Sher,et al.  Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes , 1994, The Journal of experimental medicine.

[124]  A. Sher,et al.  Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. , 1991, Journal of immunology.

[125]  A. Sher,et al.  Toxoplasma gondii soluble products induce cytokine secretion by macrophages and potentiate in vitro replication of a monotropic strain of HIV. , 1994, The Journal of eukaryotic microbiology.

[126]  G. Stryker,et al.  Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. , 1993, Journal of immunology.

[127]  I. Khan,et al.  Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice. , 1996, International immunology.

[128]  M. Demitrack,et al.  Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. , 1992, Brain : a journal of neurology.

[129]  R. de Waal Malefyt,et al.  Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals. , 1998, Journal of immunology.

[130]  M. Caligiuri,et al.  Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. , 1998, The Journal of clinical investigation.

[131]  A. Sher,et al.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.

[132]  Y. Ito,et al.  Gamma delta T cells play an important role in hsp65 expression and in acquiring protective immune responses against infection with Toxoplasma gondii. , 1995, Journal of immunology.

[133]  L. Sibley,et al.  Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. , 1997, Journal of immunology.

[134]  M. Bonneville,et al.  Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. , 1994, Science.

[135]  R. Seder,et al.  Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. , 1996, Journal of immunology.

[136]  R. McLeod,et al.  Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. , 1989, Journal of immunology.

[137]  C. Hunter,et al.  Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha , 1994, Infection and immunity.

[138]  J. K. Frenkel,et al.  Specific and nonspecific mediation of protective immunity to Toxoplasma gondii , 1987, Infection and immunity.

[139]  S. Tonegawa,et al.  Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen , 1993, Nature.

[140]  A. Sher,et al.  Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. , 1997, Journal of immunology.

[141]  J. Montoya,et al.  Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells , 1996, Infection and immunity.

[142]  A. Sher,et al.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[143]  J. Schwartzman,et al.  A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[144]  J. Montoya,et al.  Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. , 1996, The Journal of infectious diseases.

[145]  J. Remington,et al.  Unexposed Individuals in Toxoplasma gondii T Cell Response to βα , 1998 .

[146]  R. Nussenblatt,et al.  Toxoplasma gondii: Acquired Ocular Toxoplasmosis in the Murine Model, Protective Role of TNF-α and IFN-γ , 1994 .

[147]  Y. Suzuki,et al.  Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis. , 1989, Journal of immunology.

[148]  Z. Brener,et al.  Protective effects of specific antibodies in Trypanosoma cruzi infections. , 1976, Journal of immunology.

[149]  V. Tsai,et al.  Acute toxoplasma infection of mice induces spleen NK cells that are cytotoxic for T. gondii in vitro. , 1986, Journal of immunology.

[150]  A. Sher,et al.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.

[151]  A. Sher,et al.  A Role for Cd4+nki.1 + T Lymphocytes as Major Histocompatibility Complex Class Ii Independent Helper Cells in the Generation of Cd8 + Effector Function against Intracellular Infection , 1996 .

[152]  C. Hunter,et al.  Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to Toxoplasma gondii , 1995 .

[153]  K. Murphy,et al.  Through an Nf-kappa B Half-site. Regulation of Interleukin 12 P40 Expression , 1995 .

[154]  G. Trinchieri,et al.  Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. , 1997, Journal of immunology.

[155]  Qing Yang,et al.  MHC class I gene(s) in the D/L region but not the TNF-alpha gene determines development of toxoplasmic encephalitis in mice. , 1994, Journal of immunology.

[156]  P. Cresswell Antigen Presentation: Getting peptides into MHC class II molecules , 1994, Current Biology.

[157]  A. Sher,et al.  Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain. , 1996, Experimental parasitology.

[158]  M. Sporn,et al.  Deactivation of macrophages by transforming growth factor-β , 1988, Nature.

[159]  C. Hunter,et al.  Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii , 1993, Infection and immunity.

[160]  A. Sher,et al.  Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. , 1995, Ciba Foundation symposium.

[161]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[162]  Y. Ito,et al.  Induction of heat shock protein closely correlates with protection against Toxoplasma gondii infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[163]  T. Curiel,et al.  Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells. , 1993, Journal of immunology.

[164]  Y. Suzuki,et al.  Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii , 1996, The Journal of experimental medicine.

[165]  A. Sher,et al.  The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β , 1992, European journal of immunology.

[166]  C. Hunter,et al.  IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. , 1995, Journal of immunology.

[167]  A. Sher,et al.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. , 1993, Journal of immunology.

[168]  Y. Chien,et al.  RECOGNITION BY / T CELLS , 1996 .

[169]  I. Khan,et al.  Induction of gammadelta T cells during acute murine infection with Toxoplasma gondii. , 1996, Journal of immunology.

[170]  R. Saavedra,et al.  Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli. , 1991, Journal of immunology.

[171]  R. Gazzinelli,et al.  Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. , 1996, Journal of immunology.

[172]  H. Macdonald,et al.  A role for gamma delta + T cells during experimental infection of mice with Leishmania major. , 1993, Journal of immunology.

[173]  R. Gazzinelli,et al.  Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. , 1995, Current opinion in immunology.

[174]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[175]  C. Hunter,et al.  Studies on the role of interleukin-12 in acute murine toxoplasmosis. , 1995, Immunology.

[176]  A. Sher,et al.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. , 1996, Journal of immunology.

[177]  Y. Suzuki,et al.  The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. , 1990, Journal of immunology.

[178]  F. Aosai,et al.  Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes. , 1994, Journal of Parasitology.

[179]  J. Tschopp,et al.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.

[180]  W. Fiers,et al.  The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.

[181]  A. Sher,et al.  Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. , 1993, Journal of immunology.

[182]  R. Locksley,et al.  Oxygen‐dependent microbicidal systems of phagocytes and host defense against intracellular protozoa , 1983, Journal of cellular biochemistry.

[183]  S. Reed,et al.  Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta) , 1991, The Journal of experimental medicine.

[184]  A. Sher,et al.  Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. , 1994, Journal of immunology.

[185]  I. Khan,et al.  A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. , 1991, Journal of immunology.

[186]  S. Szabo,et al.  Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4 , 1995, The Journal of experimental medicine.

[187]  J. Lucet,et al.  Septic shock due to toxoplasmosis in patients infected with the human immunodeficiency virus. , 1993, Chest.

[188]  W. O'brien,et al.  Cytokines alter production of HIV-1 from primary mononuclear phagocytes. , 1988, Science.

[189]  Y. Tanaka,et al.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. , 1995, Nature.

[190]  G. Trinchieri,et al.  The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells , 1996, The Journal of experimental medicine.

[191]  J. Heesemann,et al.  Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion , 1994, Infection and immunity.

[192]  W. Paul,et al.  Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. , 1997, Journal of immunology.

[193]  O. Janssen,et al.  The primary response of human gamma/delta + T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells , 1991, The Journal of experimental medicine.

[194]  R. Flavell,et al.  Dissection of the interferon gamma‐MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s). , 1992, The EMBO journal.

[195]  C. Maliszewski,et al.  Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction , 1995, European journal of immunology.

[196]  E. Chi,et al.  Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity , 1994, The Journal of experimental medicine.

[197]  G. Trinchieri,et al.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.

[198]  C. Nathan,et al.  Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi , 1979, The Journal of experimental medicine.

[199]  R. Nussenblatt,et al.  An unusually high prevalence of ocular toxoplasmosis in southern Brazil. , 1992, American journal of ophthalmology.

[200]  S. Reed,et al.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. , 1992, Science.

[201]  J. Berzofsky,et al.  Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection , 1992, Immunological reviews.

[202]  W. Paul,et al.  Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis , 1995, Molecular and cellular biology.

[203]  J. Montoya,et al.  Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. , 1995, The Journal of clinical investigation.

[204]  W. AptB Toxoplasmosis in developing countries. , 1985 .

[205]  J. Justement,et al.  Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[206]  H. Kretzschmar,et al.  Cellular composition and distribution of gliomesenchymal nodules in the CNS of AIDS patients. , 1993, Clinical neuropathology.

[207]  Y. Suzuki,et al.  Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon , 1990, Infection and Immunity.

[208]  E. Podack Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. , 1995, Current opinion in immunology.

[209]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[210]  L. Sibley,et al.  Genetic basis of pathogenicity in toxoplasmosis. , 1996, Current topics in microbiology and immunology.

[211]  D. Bout,et al.  Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. , 1997, Journal of immunology.

[212]  B. Luft,et al.  Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. , 1984, The Journal of infectious diseases.

[213]  D. Bout,et al.  Toxoplasma gondii oral infection induces specific cytotoxic CD8 alpha/beta+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. , 1994, Journal of immunology.

[214]  Y. Chien,et al.  Recognition by gamma/delta T cells. , 1996, Annual review of immunology.

[215]  A. Sher,et al.  Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii , 1997, The Journal of experimental medicine.

[216]  R. Gerli,et al.  Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis. , 1992, Immunology.

[217]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[218]  Y. Suzuki,et al.  Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. , 1989, Journal of immunology.

[219]  P. Hohlfeld,et al.  Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mothers and fetuses , 1990, The Pediatric infectious disease journal.

[220]  A. Sher,et al.  Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. , 1997, Immunity.

[221]  K. Murphy,et al.  Regulation of interleukin 12 p40 expression through an NF-kappa B half-site , 1995, Molecular and cellular biology.

[222]  M. Zajdowicz,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1995 .

[223]  B. Luft,et al.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. , 1984, JAMA.

[224]  D. Cooper,et al.  Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS , 1992, Annals of Internal Medicine.

[225]  C. Hunter,et al.  Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates , 1994, Infection and immunity.

[226]  R. McLeod,et al.  Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. , 1995, Immunology.

[227]  A. Bollen,et al.  Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii , 1996, Infection and immunity.

[228]  C. Turck,et al.  Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. , 1993, Journal of immunology.

[229]  A. Sher,et al.  Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction , 1997, The Journal of experimental medicine.

[230]  C. Roberts,et al.  Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis , 1992, European journal of immunology.

[231]  W. Paul,et al.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.

[232]  W. Henderson,et al.  Alteration of leukotriene release by macrophages ingesting Toxoplasma gondii. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[233]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.